Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Gaëtane Simon"'
Autor:
Antoine Vasseur, Matthieu Carton, Severine Guiu, Paule Augereau, Lionel Uwer, Marie-Ange Mouret-Reynier, Christelle Levy, Jean-Christophe Eymard, Jean-Marc Ferrero, Marianne Leheurteur, Anthony Goncalves, Marie Robert, Thibault De La Motte Rouge, Thomas Bachelot, Thierry Petit, Marc Debled, Thomas Grinda, Isabelle Desmoulins, Laurence Vanlemmens, Vincent Nicolaï, Gaëtane Simon, Luc Cabel
Publikováno v:
Breast, Vol 65, Iss , Pp 136-144 (2022)
Background: Taxanes are one of the most effective chemotherapies (CT) in breast cancer (BC), but the efficacy of taxanes rechallenge in early metastatic relapse has been poorly studied in patients previously treated by taxanes in the (neo)adjuvant se
Externí odkaz:
https://doaj.org/article/3e5e3d1b6d254f9091fd5376422aa2e4
Autor:
Audrey Mailliez, Suzette Delaloge, Marie-Ange Mouret-Reynier, Jean-Marc Ferrero, Gaëtane Simon, Jean-Sebastien Frenel, Amélie Lusque, Thibault De La Motte Rouge, Laurence Gladieff, Olivier Caron, Thierry Petit, A. Gonçalves, Luc Cabel, Jean-Christophe Eymard, Marc Debled, Véronique D'Hondt
Publikováno v:
Cancer Research. 81:PD10-08
BACKGROUND: Approximately 5% of breast cancer (BC) patients (pts) carry a deleterious germline BRCA mutation (gBRCAm). Retrospective studies suggest that overall survival (OS) is equivalent between gBRCAm carriers and non-carriers with metastatic BC
Autor:
Jean-François Honart, Elvire Pons-Tostivint, Thierry Petit, Clémentine Jankowski, Sophie Guillermet, Amélie Lusque, Gaëtane Simon, Marc Debled, Jean-Marc Ferrero, Thomas Bachelot, Audrey Mailliez, Marian Gutowski, Léa Leufflen, Brigitte De La Lande, Nicolas Pouget, Mario Campone, Marianne Leheurteur, Jean-Christophe Eymard, Olivier Villacroux, Frédéric Marchal, Anthony Gonçalves, Jean-Sebastien Frenel, Judicaël Hotton, Christelle Levy
Publikováno v:
Annals of Surgery. 277:e153-e161
OBJECTIVE The aim was to evaluate the impact of local surgery performed during the year following metastatic breast cancer (MBC) diagnosis on patients' outcomes from a large real-life cohort. SUMMARY BACKGROUND DATA Locoregional treatment for patient
Autor:
Michel Velten, Gaëtane Simon, Frédérique Penault-Llorca, Anthony Gonçalves, Marion Bertho, Jean-Marc Ferrero, Marianne Leheurteur, Michaël Chevrot, Florence Dalenc, Roman Rouzier, Anne Jaffre, Marie-Paule Lebitasy, Véronique D'Hondt, Suzette Delaloge, Anne Patsouris, Lionel Uwer, Patrick Arveux, Christelle Levy, David Pérol, Jean-Sebastien Frenel, Jean-Christophe Eymard, Mathias Breton, Julien Fraisse, Paul Cottu
Publikováno v:
Cancer Research. 80:P2-19
Background: Bone-only (BO) metastatic breast cancer (MBC), defined as bone as unique site of metastasis at MBC diagnosis, is thought to carry a better prognosis among MBC. However, only small retrospective series and data from selected randomized con
Autor:
Anthony Gonçalves, Gaëtane Simon, Thierry Petit, Jean-Christophe Eymard, Christelle Levy, David Pérol, Monica Arnedos, Florence Dalenc, Jean-Sebastien Frenel, Michaël Chevrot, Sébastien Thureau, Véronique D'Hondt, Julien Fraisse, Paul Cottu, Mathias Breton, Lionel Uwer, Anne Jaffre, Jean-Marc Ferrero, Frédérique Penault-Llorca, Marion Bertho, Roman Rouzier, Marie-Paule Lebitasy, Anne Patsouris, Sandrine Dabakuyo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, SAGE Journals, 2021, 13, pp.175883592098765. ⟨10.1177/1758835920987657⟩
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, SAGE Journals, 2021, 13, pp.175883592098765. ⟨10.1177/1758835920987657⟩
Background: Bone-only (BO) metastatic breast cancer (MBC) is considered a more favorable entity than other MBC presentations. However, only few retrospective series and data from selected randomized controlled trials have been reported so far. Method
Autor:
Marie-Ange Mouret-Reynier, Véronique D'Hondt, Audrey Mailliez, Gaëtane Simon, Damien Parent, Silvia Ilie, N. Madranges, Christelle Levy, David Pérol, Gaëlle Chenuc, Pierre Heudel, Thomas Vermeulin, Lionel Uwer, Paule Augereau, Thierry Petit, Suzette Delaloge, Florence Dalenc, Christophe Perrin, Etienne Brain, Jean-Sebastien Frenel, Anthony Gonçalves, Jean-Christophe Eymard, Jean-Marc Ferrero, Mathieu Robain, Marie-Paule Sablin
Publikováno v:
Anticancer Research
Anticancer Research, International Institute of Anticancer Research, 2020, 40 (7), pp.3905-3913. ⟨10.21873/anticanres.14381⟩
Anticancer Research, International Institute of Anticancer Research, 2020, 40 (7), pp.3905-3913. ⟨10.21873/anticanres.14381⟩
Background/aim Vinorelbine is indicated for use in the treatment of MBC as a single agent or in combination but there is little real world data on this molecule and even less on its oral form. We exploited the Unicancer Epidemiology Strategy Medical-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617a1f7090bc6531688599f52d2e7eb4
https://hal.archives-ouvertes.fr/hal-02995541
https://hal.archives-ouvertes.fr/hal-02995541
Autor:
Gaëtane Simon, Alexia Savignoni, E. Brain, E. Kaczmarek, J-Y Pierga, Emmanuelle Mouret-Fourme, Coraline Dubot, Roman Rouzier, Florence Lerebours, Matthieu Carton, C. Saint-Martin
Publikováno v:
Cancer Research. 78:P5-21
Background About 20% of breast cancer (BC) patients will develop distant metastases. HER2-positive (HER2+) disease is associated with poorer prognosis. However, outcome of HER2+ BC patients has dramatically improved since the use of trastuzumab. Alth
Autor:
J-M Ferrero, Sylvie Chabaud, A. Monneur, Florence Dalenc, Gaëtane Simon, Audrey Mailliez, T. de La Motte Rouge, Florence Lerebours, Barbara Pistilli, Séverine Guiu, Thierry Petit, M. Campone, A. Gonçalves, C. Levy, Bruno Coudert, Audrey Lardy-Cleaud, N Quenel-Tueux, M.-A. Mouret-Reynier, D. Dano, François Bertucci
Publikováno v:
ESMO Open
ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩
ESMO Open, European Society for Medical Oncology, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩
ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩
ESMO Open, European Society for Medical Oncology, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩
Background Primary inflammatory breast cancer (IBC) is a rare and aggressive entity whose prognosis has been improved by multimodal therapy. However, 5-year overall survival (OS) remains poor. Given its low incidence, the prognosis of IBC at metastat
Autor:
Jean-Marc Ferrero, Jean-Yves Pierga, Marc Debled, Luc Cabel, Florence Dalenc, Irwin Piot, Bianca Cheaib, Isabelle Desmoulins, Christelle Levy, David Pérol, Anthony Gonçalves, Audrey Mailliez, Marie-Ange Mouret-Reynier, Matthieu Carton, Florence Lerebours, Gaëtane Simon, Claudia Lefeuvre, Jean-Christophe Eymard, Thierry Petit, Marianne Leheurteur, William Jacot, Geneviève Perrocheau, Lionel Uwer
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2018, ⟨10.1007/s10549-018-5017-2⟩
Breast Cancer Research and Treatment, 2018, ⟨10.1007/s10549-018-5017-2⟩
Breast Cancer Research and Treatment, Springer Verlag, 2018, ⟨10.1007/s10549-018-5017-2⟩
Breast Cancer Research and Treatment, 2018, ⟨10.1007/s10549-018-5017-2⟩
HER2-negative metastatic breast cancer (MBC) is a common setting in which chemotherapy could be effective even in later lines of treatment. Oral etoposide has demonstrated clinical activity in this setting in small-scale studies, but its efficacy has
Autor:
Julien Fraisse, Christelle Levy, Isabelle Desmoulins, Véronique Diéras, Monica Arnedos, Anthony Gonçalves, Laurence Vanlemmens, Jean-Marc Ferrero, Thierry Petit, Lauriane Eberst, Gaëtane Simon, Laetitia Collet, Thomas Bachelot, Marc Debled, Marianne Leheurteur, Etienne Brain, Florence Dalenc, Mario Campone, Marie-Ange Mouret-Reynier, Amélie Darlix
Publikováno v:
Journal of Clinical Oncology. 38:2527-2527
2527 Background: Isolated central nervous system (CNS) progression on first-line systemic therapy with Trastuzumab (T) and Pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) is a therapeutic challenge. Our aim was to describe the clinica